Although eukaryotic nuclei contain distinct architectural structures associated with noncoding RNAs (ncRNAs), their potential relationship to regulated transcriptional programs remains poorly understood. Here, we report that methylation/demethylation of Polycomb 2 protein (Pc2) controls relocation of growth-control genes between Polycomb bodies (PcGs) and interchromatin granules (ICGs) in response to growth signals. This movement is the consequence of binding of methylated and unmethylated Pc2 to the ncRNAs TUG1 and MALAT1/NEAT2, located in PcGs and ICGs, respectively. These ncRNAs mediate assembly of multiple corepressors/ coactivators and can serve to switch mark recognition by ''readers'' of the histone code. Additionally, binding of NEAT2 to unmethylated Pc2 promotes E2F1 SUMOylation, leading to activation of the growth-control gene program. These observations delineate a molecular pathway linking the actions of subnuclear structure-specific ncRNAs and nonhistone protein methylation to relocation of transcription units in the threedimensional space of the nucleus, thus achieving coordinated gene expression programs.
INTRODUCTION
Regulated programs of gene expression are defined by the concerted interplay of transcriptional factors as well as other modulators such as epigenomic and signaling mediators. Recent studies have begun to elucidate the mechanistic control of gene expression by modulation of nuclear architecture and noncoding RNA (ncRNA) (Mercer et al., 2009; Misteli, 2010; Wilusz et al., 2009) , suggesting the crosstalk between subnuclear architectural features and ncRNA as a possible mechanism for controlling gene expression. Thus, a growing number and type of molecular strategies combinatorially contribute to the precise control of gene expression involved in proliferation, differentiation, and maturation of cells.
In regulation of cell proliferation, the E2F family of transcription factors plays a critical role in organizing early cell-cycle progression by coordinating early cell-cycle events with the transcription of genes required for entry into S phase (Nevins, 1992) . The transcriptional activity of E2F1 is regulated principally by association with different factors including the Rb-E2F complexes, which predominate in quiescent cells, acting as repressors of transcription (Bagchi et al., 1991) . Other levels of control that influence E2F1 activity include its posttranslational modifications, protein stabilization (Campanero and Flemington, 1997) , and regulation of its intracellular location (de la Luna et al., 1996) .
At the level of ''epigenomic control,'' a large and growing class of proteins, known as chromatin modifiers, constrains expression by adapting regions of the genome to maintain either gene silencing or gene activation (Kouzarides, 2007) . Histone methylation, together with other site-specific modifications, plays an important role in the generation of specific molecular marks in chromatin, which are recognized by regulatory proteins, thus determining dynamic transitions between transcriptionally active and inactive states (Jenuwein and Allis, 2001) . Recent data also show that the regulatory role of lysine methylation on proteins is not restricted to the ''histone code'' with this modification modulating activation, stabilization, and degradation of nonhistone proteins, thus influencing numerous cell processes (Huang and Berger, 2008) . A number of histone methyltransferases (HMTases) that can methylate specific lysine residues of histones and certain nonhistone substrates have been identified and characterized (Chuikov et al., 2004; Sampath et al., 2007; Subramanian et al., 2008) . Suv39h1 is an H3 lysine 9 methyltransferase containing the conserved SET domain and post-SET domains (Aagaard et al., 1999) . It is documented that Suv39h1-mediated histone methylation functions in transcription repression and gene silencing by recruitment of Polycomb proteins and forming and spreading heterochromatin .
Genetic study of Suv39h1 transgenic mice has demonstrated that overexpression of Suv39h1 accelerates homeostatic cell proliferation (Czvitkovich et al., 2001) , whereas Suv39h1/h2 double null mice have reduced viability during embryonic development and reduced growth as adult animals . Furthermore, Suv39h1 forms a complex with pRb/E2F1 and plays a role in the dynamic regulation of specific cell-cycle genes needed for entry into the S phase (Ait-Si-Ali et al., 2004; Nielsen et al., 2001 ). These observations suggest that Suv39h1 may function as a transcriptional corepressor of the E2F1 transcription factor. Indeed, Suv39h1 selectively interacts with vertebrate chromobox family (Cbx) proteins, including heterochromatin protein 1 (HP1) and Cbx4 (Pc2) (Sewalt et al., 2002) . Although Cbx proteins are thought to function as repressors in heterochromatin formation and gene silencing, recent evidence has demonstrated that Cbx proteins also play a critical role in cell-cycle progression (Satijn et al., 1997) . However, the role of Pc2 in cell-cycle regulation remains largely unknown.
The notion that ncRNAs can have numerous molecular functions is rapidly evolving (Eddy, 2001; Ponting et al., 2009) . Even though long ncRNAs represent a large class of transcriptional units and appear to be evolutionarily conserved, their specific roles in critically modulating regulated gene expression remain poorly understood.
Here, we report a critical role of Suv39h1-mediated Pc2 methylation in regulating the cellular proliferation program, causing a relocation of growth-control gene loci from Polycomb bodies (PcGs) to interchromatin granules (ICGs) upon serum stimulation. We show that ncRNAs TUG1 and NEAT2 cause the growthcontrol genes to relocate from the repressive environment of PcG bodies, where they interact with corepressor complexes, to the gene activation milieu of the ICGs, by selectively interacting with methylated and unmethylated Pc2 present on growthcontrol gene promoters, respectively. Interaction with NEAT2 regulates Pc2-dependent E2F1 SUMOylation, which licenses the recruitment of an H2B monoubiquitinase, CDCA7L, and biochemically switches the Pc2 chromodomain from preferring repressive histone marks to interacting with activation-associated histone marks. Broadly, our data highlight combinational actions of transcription factor/coregulators, nonhistone protein methylation, and ncRNAs resident in distinct subnuclear architectural structures as a central strategy to achieve coordinated programs of regulated gene expression, with implications for our understanding of the epigenomic programming in homeostasis and disease.
RESULTS

Pc2
Is a Substrate for Suv39h1, a Lysine-Specific Methyltransferase We searched for nonhistone candidate substrates for Suv39h1 and found that Suv39h1 methylated Pc2 in vitro (Figures 1A and S1A-S1C). Under our assay conditions, Suv39h1-mediated methylation of Pc2 appeared to be quite specific. Other proteins such as SUMO1, SUMO-activating enzyme E1, E2, and E2F1 did not serve as Suv39h1 substrates ( Figure 1A ). Moreover, a Suv39h1 hyperactive mutant (H320R) (Rea et al., 2000) further enhanced the methylation of Pc2, whereas an enzymatically inactive Suv39h1 mutant (H324L) (Rea et al., 2000) failed to use Pc2 as substrate ( Figures 1B and S1A ). Trypsin digestion of immunoprecipitated FLAG-Pc2 from 293T cells coexpressed with wild-type (WT) Suv39h1 ( Figure 1C, arrow) , followed by mass spectrometry (MS), revealed that lysine 191 of Pc2 was dimethylated, which was not observed in cells overexpressed with enzymatically inactive Suv39h1 mutant (H324L) ( Figure 1C and data not shown). A single K191R point mutation completely abolished Pc2 methylation, suggesting that K191 serves as a sole methylation site targeted by Suv39h1 ( Figures 1D and S1D) .
To investigate the role of Pc2 methylation in vivo, we generated rabbit polyclonal antibodies that specifically recognized dimethylated Pc2K191 and unmethylated Pc2 ( Figure S1E ). The anti-Pc2K191-dimethyl antibody (referred to as Pc2K191me 2 antibody) specifically detected bacterially purified Pc2 protein methylated by Suv39h1 in vitro but was totally unreactive against unmethylated Pc2 protein, whereas anti-Pc2K191 antibody (referred to as Pc2K191 antibody) specifically recognized unmethylated Pc2 protein with no cross-reaction to methylated Pc2 protein when equivalent amounts of methylated and unmethylated Pc2 were used ( Figure 1E ). We concluded that the Pc2K191me 2 and Pc2K191 antibodies specifically recognized K191-methylated and -unmethylated Pc2, respectively. To address whether Pc2 is methylated by Suv39h1 in vivo, we knocked down Suv39h1 and other histone H3K9 methyltransferases including Suv39h2, G9a, EuHMT, and ESET by specific siRNAs in HeLa cells and observed that the Pc2K191me 2 level was specifically reduced only by Suv39h1 siRNA compared to control siRNA, with a concurrent increase of unmethylated Pc2 level ( Figures 1F and S1F ). To rule out any potential off-target effects of Suv39h1 siRNA, WT Suv39h1 or its enzymatically inactive mutant form (H324L) was transiently expressed in HeLa cells. Immunoblotting analysis using Pc2K191me 2 antibody detected increased levels of Pc2 methylation in extracts derived from cells overexpressing the WT Suv39h1, whereas cells equivalently transfected with the enzymatically inactive H324L mutant displayed minimal, if any, Pc2 methylation ( Figure 1G ). The expression levels of Suv39h1 proteins and the amount of total proteins in extracts were similar ( Figure 1G ). We therefore conclude that Suv39h1 methylates Pc2 at K191 in vivo.
Growth-Control Gene Activation Requires KDM4C-Mediated Pc2K191me 2 Demethylation Interestingly, Pc2K191 exists in a sequence context resembling that of histone H3K9, which led us to search for candidate H3K9 demethylases that may demethylate Pc2K191me 2 . By performing an in vitro demethylation assay using active FLAG-H3K9 demethylases purified from 293T cells ( Figures S2A and S2B) , we found that, in addition to histone H3K9me 2 , KDM4C demethylated the dimethyl Pc2K191 ( Figure 2A ). Under our assay conditions, KDM4C-mediated demethylation of Pc2K191me 2 appeared to be quite specific, as other demethylases, including KDM3A, KDM4A, KDM4B, KDM4C, KDM4D, and PHF8, did not serve as Pc2K191me 2 demethylases although each of the purified demethylases exhibited robust enzymatic activity on an H3K9me 2 substrate ( Figure S2B ). Moreover, the enzymatically inactive KDM4C-H190G/E192A mutant (Cloos et al., 2006) failed to demethylate Pc2K191me 2 ( Figures 2B and S2C ).
To investigate the potential role of Pc2 in cell-cycle and growth control, we next analyzed whether KDM4C-mediated demethylation of Pc2 regulates the transcriptional activation of E2F1 target genes. First, we examined whether Pc2K191me 2 level is physiologically regulated under the conditions of E2F1 activation. Immunoprecipitation experiments with Pc2K191me 2 and Pc2K191 antibodies revealed that Pc2K191me 2 levels exhibited a strong decrease in response to serum stimulation, concurrent with increased levels of unmethylated Pc2 ( Figure 2C ). We further examined the methylation status of Pc2 on E2F1 target gene promoters previously identified by E2F1 ChIP-seq (Liu et al., 2010) , finding that Pc2K191me 2 specifically enriched on E2F1 target gene promoters, in contrast to no significant occupancy on the Actin promoter, which is not regulated by Polycomb proteins ( Figure 2D , left panel). Importantly, Pc2K191me 2 levels dramatically decreased upon serum stimulation, which correlates with the increased levels of unmethylated Pc2 ( Figure 2D , Figure 2D ).
Chromatin immunoprecipitation (ChIP) assays in HeLa cells transfected with KDM4C WT or H190G/E192A mutant revealed that serum stimulation resulted in increased recruitment of WT KDM4C on E2F1 target gene promoters ( Figure 2E ), which correlated with a decreased Pc2K191me 2 level ( Figure 2F ). The KDM4C-H190G/E192A mutant largely inhibited Pc2K191me 2 demethylation, despite being equally recruited on the same set of promoters ( Figures 2E and 2F ). Indeed, siRNA-mediated reduction of the levels of KDM4C also impaired the expression of E2F1 target genes upon serum stimulation in HeLa cells (Figures 2G and S2D) . To further evaluate the alternative possibility that the actions of KDM4C that critically dictate growthcontrol gene expression might reside in its histone H3K9 demethylase activity, rather than actions on Pc2K191me 2 , we took advantage of the previous observations that different H3K9 demethylases are utilized in a promoter-specific fashion to provide H3K9 demethylase activity (Fodor et al., 2006; Qi et al., 2010; Yamane et al., 2006) . We found that growth-control gene promoters did not exhibit a KDM4C dependence on H3K9me 2 demethylation ( Figure S2E , bottom panel), yet demethylase activity of KDM4C was required for the demethylation of Pc2K191me 2 and for activation for these growth-control genes (Figures S2E, top panel and 2G) . Taken together, these data argue strongly that it is the specific demethylation of the repressive dimethyl Pc2K191 mark, caused by recruitment of KDM4C, rather than H3K9 demethylation, that is required for the transcriptional activation of E2F1 target genes.
Pc2 Methylation/Demethylation Controls the Cell-Growth Program
Considering the involvement of KDM4C-mediated Pc2K191me 2 demethylation on E2F1 target gene promoters in response to serum, we tested the possibility that Pc2 methylation/demethylation is required for controlling the growth-control gene expression and cell proliferation. Knockdown of Pc2 in HeLa cells dramatically decreased serum-induced growth-control gene expression and cell proliferation ( Figures 3A, 3B , and S3A). In accord with this finding, exogenous expression of Pc2 K191R mutant noticeably increased cell proliferation even at the basal level, further indicating that Pc2 is a potent regulator of the cell-growth program ( Figure 3C ).
The potential requirement of Pc2 in mitogenic signal-induced proliferation was next investigated in primary human fibroblasts. IMR-90 primary human lung fibroblasts became growth arrested with serum starvation and proliferated once released into serumcontaining medium (Nahle et al., 2002) . Immunoblotting showed that, although global Pc2 protein levels were not affected, serum stimulation of IMR-90 cells was largely accompanied by Pc2K191me 2 demethylation ( Figure 3D ). Pc2 shRNAs (shPc2-1 and -2) dramatically reduced Pc2 protein levels when stably transduced into IMR-90 cells and impaired serum-induced cell proliferation ( Figures 3E and S3B ). Collectively, our data suggest that methylated Pc2 may represent an important antimitogenic signal and, under certain stimuli, a stress-induced modification mark required for growth-control gene repression and cell-cycle arrest, whereas unmethylated Pc2 is essential for physiological growth-control gene expression and cell proliferation.
Serum Induction Causes Relocation of E2F1-Regulated Genes between PcG Bodies and ICGs
We speculated that, given the involvement of Pc2 in stable gene repression (Lund and van Lohuizen, 2004) , E2F1-regulated growth-control genes might relocate within the cell nuclei from transcriptional repressive PcG bodies to a transcriptionally permissive environment upon serum stimulation. We first examined the subnuclear localization of methylated and unmethylated Pc2. We observed that methylated Pc2 was concentrated in several defined domains that were faithfully costained with Bmi1 and Ring1A ( Figures 4A and 4B ), two well-established PcG body markers (Herná ndez-Muñ oz et al., 2005) . In contrast, unmethylated Pc2 showed strong colocalization only with SC35, a marker for the ICGs (Fu and Maniatis, 1990 ) ( Figure 4C ). Under our immunostaining conditions, colocalization of unmethylated Pc2 with ICGs appeared to be quite specific. Other nuclear bodies, including nuclear stress bodies, paraspeckles, Cajal bodies, and promyelocytic leukemia (PML) bodies, failed to exhibit costaining with unmethylated Pc2 (data not shown). We then performed immuno-FISH to test whether Pc2-associated E2F1 target transcription units relocated from PcG bodies to ICGs upon serum stimulation. Interestingly, gene loci encoding growth-control genes (RBL1, MCM3, PCNA, and MSH2) were found to predominantly colocalize with PcG bodies, as marked by Pc2K191me 2 staining (or Ring1A, see below) in serum-starved HeLa cells, and these loci largely colocalized with SC35-staining ICGs in the presence of serum ( Figures 4D and S4A vector, FLAG-KDM4C WT, or H190G/E192A mutant were serum-starved followed by restimulation, and ChIP analyses using FLAG antibody (E) or Pc2K191me 2 antibody (F) were performed on indicated regions. (G) KDM4C is required for serum-induced growth-control gene expression. HeLa cells transfected with control or validated KDM4C siRNAs were serum-starved followed by restimulation, and relative mRNA levels of indicated genes were determined by qRT-PCR. Mean ± SEM, *p < 0.05. See also Figure S2 .
the same conditions, colocalization of E2F1 target gene loci with PcG bodies was reproducibly observed in immuno-FISH experiments using Ring1A, instead of Pc2K191me 2 , staining as a marker for PcG bodies ( Figure 4E ). In contrast, unmethylated Pc2 specifically colocalized with activated E2F1 target gene loci upon serum stimulation ( Figures S4D-S4G) . It was previously shown that ICGs occupy the large space in nuclei, which results in a 14%-26% ''unspecific'' colocalization with genes under basal conditions (Szczerbal and Bridger, 2010) . It is to be expected that any given gene locus may also exhibit a similar 15%-25% ''unspecific'' colocalization with ICGs. To further support this assumption, we performed immuno-FISH on a cell-cycle-unrelated gene locus BCR, finding an average of 10% and 30% colocalization of this locus with PcG bodies and ICGs in serumstarved cells, respectively, and that these colocalization percentages did not change upon serum stimulation ( Figure S4H ). Thus, given the assay background, the actual percent of relocation of growth-control genes from PcG bodies to ICGs would be considerably greater if this background were to be subtracted.
As expected, knockdown of Pc2 impaired the colocalization of MCM3 with both PcG bodies and ICGs ( Figure 4F ). Interestingly, other core components of the PRC1 complex including Bmi1 and PHC1 (Simon and Kingston, 2009 ) specifically interacted with methylated Pc2 (Figure 4G ), and siRNA knockdown of these components disrupted the colocalization of MCM3 with PcG bodies, but not ICGs, although having no obvious effects on maintenance of PcG bodies ( Figures 4F, S4I , and S4J), suggesting that other components of the PRC1 complex may facilitate the repression of growth-control genes mediated by methylated Pc2 in PcG bodies.
We next tested whether demethylation of Pc2K191me 2 is required for the relocation process in HeLa cells microinjected with specific siRNAs against KDM4C, and we found that depletion of KDM4C largely abrogated dissociation of the MCM3 gene locus from PcG bodies in the presence of serum stimulation (Figure 4H ). In contrast, microinjection of plasmid encoding the Pc2K191R mutant in serum-starved cells resulted in dissociation of the MCM3 gene locus from the Ring1A-stained PcG bodies, (A and B) Pc2 is essential for serum-induced growth-control gene expression and cell proliferation. HeLa cells transfected with Pc2 siRNAs were serum-starved followed by restimulation, and mRNA levels of indicated genes (A) and cell proliferation (B) were analyzed, respectively. (C) Pc2K191 methylation is a key regulator for cell proliferation. HeLa cells transfected with Pc2 plasmids (WT or K191R mutant) were serum-starved followed by restimulation, and cell proliferation was analyzed. (D and E) IMR-90 cells were serum-starved followed by restimulation, and Pc2K191 methylation level (D) and cell proliferation (E) were analyzed by immunoblotting and flow cytometry, respectively. For (B), (C) , and (E), cell proliferation was analyzed by monitoring the EDU incorporation into DNA synthesis in S phase cells. Mean ± SEM, *p < 0.05 and **p < 0.01. See also Figure S3 .
while enhancing their colocalization with SC35-positive ICGs at basal level ( Figure 4I ). Together, these findings reveal an unexpected role of Pc2 in transcriptional regulation of growth-control genes by promoting the relocation of these gene loci from the transcriptionally repressive nuclear environment of PcG bodies to the transcriptionally permissive environment of ICGs. Given the observation that siRNA knockdown of KDM4C exerted no effect on serum-induced demethylation of H3K9me 2 on growth-control gene promoters ( Figure S2E ), we concluded that the KDM4C-dependent demethylation of Pc2K191me 2 , rather than histones, appears to serve as the key determinant of the relocation of growth-control genes in response to growth signals.
Methylation Modulates Pc2 Association with ncRNAs
It has been reported that ncRNA may serve as a component to form subnuclear bodies and maintain their integrity (Bond and Fox, 2009) . Given that methylated and unmethylated Pc2 are localized to PcGs and ICGs, respectively, and previous observations that the chromodomain is capable of binding RNA (Akhtar et al., 2000) , we therefore tested the possibility that Pc2 might bind specific ncRNAs in these subnuclear structures. By performing in vivo crosslinking and immunoprecipitation procedures (CLIP) using either Pc2K191me 2 or Pc2K191 antibodies, we observed that specific RNA-methylated Pc2 and RNA-unmethylated Pc2 complexes were formed after the UV crosslinking, which was significantly disrupted upon adding the blocking peptides for Pc2K191me 2 and Pc2K191 antibodies in cell lysates ( Figure 5A ). Sequence analysis of 94 different clones identified TUG1, a ncRNA interacting with EZH2 previously identified by RIP assay (Khalil et al., 2009 ) and repressing cell-cycle genes, as the most enriched RNA that interacted with methylated Pc2 ( Figure S5A) . Surprisingly, in the absence of K191 methylation, the predominant RNA associated with Pc2 was NEAT2/MALAT1 ( Figure S5B ), an exclusive signature ncRNA for ICGs (Hutchinson et al., 2007) . Likewise, purified biotinylated TUG1 RNA (nt 117-3390) harboring the binding sequence identified in the CLIP assay specifically selected methylated Pc2 from HeLa cell nuclear extract, whereas biotinylated NEAT2 RNA (nt 2281-5611) specifically bound unmethylated Pc2 ( Figures 5B, S5C , and S5D). Electrophoretic mobility shift assays (EMSAs) were next used to analyze whether a direct switch of Pc2 RNA-binding preference is observed in response to K191 methylation. Incubation of the TUG1 RNA probe with methylated Pc2 resulted in specific gel retardation ( Figure 5C , first panel, lane 3), whereas incubation of only a 49 nt NEAT2 RNA probe with unmethylated Pc2 specifically resulted in gel shift ( Figure 5C , third panel, lane 4). Under these conditions, no shift was observed when the corresponding TUG1 and NEAT2 DNA probes or cold probes were used ( Figures 5C and S5E) . We, therefore, conclude that the interactions of methylated or unmethylated Pc2 with ncRNAs are controlled by a specific covalent modification of Pc2.
ncRNA-Pc2 Interactions Underlie Relocation and Transcriptional Regulation of Growth-Control Genes Pc2 has been characterized as a ''reader'' for the histone code through its chromodomain (Bernstein et al., 2006 Figures S5I and S5J) . Collectively, our results now suggest a mechanism by which ncRNAs can regulate reading of the histone code by chromatin-binding domains of various regulatory cofactors. In this case, ncRNA interacting with a chromodomain switches preferential binding from repressive to activation histone marks. ICG-specific localization of NEAT2 (Hutchinson et al., 2007 ) led us to examine the cellular localization of TUG1 by utilizing a molecular beacon targeting TUG1. Single-cell nuclear microinjection of the TUG1 molecular beacon followed by immunostaining suggested that part of TUG1 localization overlapped with methylated Pc2 staining, suggesting the localization of TUG1 within the PcG bodies ( Figure 5G) . Thus, the subnuclear structure-specific localization of TUG1 and NEAT2 may indicate that they serve as the actual docking sites responsible for relocation of Pc2-bound growth-control gene promoters. Indeed, knockdown of TUG1 caused a dramatic redistribution of growthcontrol gene promoters out of PcG bodies ( Figures 5H and S5K ), which correlated with increased gene expression ( Figure 5I ) and cell proliferation, even in the absence of serum ( Figure 5J ). Conversely, removal of NEAT2 disrupted the colocalization of the MCM3 gene locus with ICGs ( Figures 5H and S5K ) and caused loss of serum-induced gene expression ( Figure 5I ) and of cell proliferation ( Figure 5J ), although structures of the PcG bodies and ICGs were not discernibly affected by knocking down TUG1 ( Figure S5L ) and NEAT2 (Clemson et al., 2009 ) and serum treatment ( Figure S5M) .
Next, we used RNA pull-down experiments to identify the proteins associated with TUG1 and NEAT2. The experiment performed here calls for washes with buffer containing 1000 mM salt, which definitively results in relatively low backgrounds in pull-downs and does not disrupt association of TUG1 and NEAT2 with proteins. MS analysis on proteins pulled down by biotinylated TUG1 and NEAT2 revealed that TUG1 RNA specifically bound to a number of proteins involved in transcriptional repression, including histone methyltransferases/ demethylases and chromatin modifiers ( Figure 5K ; Tables S1 and S2), whereas NEAT2 RNA bound to functionally distinctive cofactors associated with gene activation including transcriptional coactivators, histone methyltransferases/demethylases associated with transcriptional activation, and pre-mRNA splicing factors ( Figure 5K ; Tables S1 and S3), suggesting that ncRNAs may impose a chromatin-remodeling environment by selectively interacting with chromatin modifier proteins. Intriguingly, TUG1 interacted with Coronin2A, which is a corepressor based on actin oligomerization (Huang et al., 2011) , whereas LSD1 interacted with NEAT2, consistent with previous observations that LSD1 colocalizes with transcription units in ICGs (Hu et al., 2008) .
Unmethylated Pc2 Mediates Serum-Induced E2F1 SUMOylation
We next examined the functional roles of unmethylated Pc2 in growth-control gene activation. Immunoblotting of E2F1 immunoprecipitates from denatured cell lysates unexpectedly revealed an upshifted E2F1 band induced by serum stimulation, which was not due to an E2F1-associated protein but rather a posttranslational modification ( Figures 6A and S6A ). Immunoblotting using antibody specific against SUMO1 and SUMO2/3 confirmed that E2F1 and E2F6, but not E2F4, were SUMO1 modified ( Figures 6A, S6B , and S6C). In searching for cellular components responsible for E2F1 SUMOylation, we observed a decreased E2F1 SUMOylation with depletion of Ubc9 and Pc2, but not other candidate E3 ligases tested ( Figures 6B and S6D ). When Pc2 was cotransfected with Myc-SUMO1, we observed a significant increase in E2F1 SUMOylation in vivo ( Figure S6E ). The fact that Pc2 directly mediated E2F1 SUMOylation was further confirmed in vitro ( Figure 6C ). To map the SUMOylation site, charge-conserving E2F1 lysine to arginine point mutants were tested for SUMOylation, revealing that the E2F1 K266R mutant showed deficient SUMOylation both in vivo and in vitro ( Figures 6D, 6E , and S6F). Although E2F1 and E2F1 K266R localized equally on the promoters of E2F1 target genes, the E2F1 K266R mutant largely inhibited serum-induced gene expression, which was not due to any effects of K266R mutation on E2F1 stability or its interaction with Rb ( Figures 6F, S6G , and S6H). Together, these results have revealed a requirement for Pc2-mediated E2F1 K266 SUMOylation or stabilization of this SUMOylation for the transcriptional activation of growth-control genes.
The observation that expression of the Pc2K191R mutant, which exerted no effects on endogenous levels of Ubc9, noticeably enhanced E2F1 SUMOylation ( Figures 6G and S6I ) led us to explore whether ncRNAs might modulate E2F1 SUMOylation mediated by Pc2. We first tested whether Pc2-regulated E2F1 SUMOylaton was RNA dependent. Treatment of Pc2K191me 2 immunoprecipitates with RNase I slightly enhanced E2F1 SUMOylation, whereas the same treatment impaired E2F1 SUMOylation mediated by Pc2K191 immunoprecipitates ( Figure 6H) . Consistently, the inhibitory activity of TUG1 on E2F1 SUMOylation was observed in performing an in vitro SUMOylation assay, with the addition of TUG1 RNA abolishing the enhanced E2F1 SUMOylation mediated by methylated Pc2 ( Figure 6I, right panel, lane3) . Taken together, our findings suggest that Pc2-mediated E2F1 SUMOylation at K266, which was modulated by interactions with ncRNAs, is required for the activation of cell-growth-control genes in response to serum.
CDCA7L Links E2F1 SUMOylation and H2B Ubiquitination in Growth-Control Gene Activation
The functional binding of SUMOylated proteins to the SUMOinteracting motif (SIM)-containing proteins plays critical roles in many biological processes including transcriptional activation, cell growth/differentiation, and DNA-damage response (Kerscher, 2007) . Thus, we searched for the potential SIM-containing proteins that can recognize the E2F1 K266 SUMOylation and its functional role in regulating growth-control gene activation. Analysis by MS of a protein exclusively copurified with WT E2F1, but not the K266R mutant, identified it as CDCA7L/ JPO2/RAM2 ( Figures 7A, S7A , and S7B), a cell-cycle regulator with a conserved RING domain (Huang et al., 2005) . The specific interaction between SUMOylated E2F1 and CDCA7L was mediated by a SIM located N-terminal of CDCA7L, and mutations in this motif (V100/103A) abolished the interaction with SUMOylated E2F1 (Figure 7B ). Consistent with the specific recruitment of CDCA7L on the E2F1 target gene promoters upon serum stimulation ( Figure 7C ), knockdown of CDCA7L by shRNAs blocked serum-induced expression of E2F1 target genes ( Figures 7D and S7C ). CDCA7L possesses a conserved RING finger domain, a characteristic of RING-class E3 ubiquitin protein ligases (Deshaies and Joazeiro, 2009 ). We therefore screened potential substrates of CDCA7L by both in vivo and in vitro ubiquitination assay, finding that CDCA7L strongly stimulated H2B monoubiquitination at K120 (Figures S7D-S7F ). These results indicate that the RING finger of CDCA7L is required for the monoubiquitination of H2B, and perhaps additional substrates, critical for transcriptional activation of growth-control genes.
Analysis by ChIP assay of UbH2B and H2B enrichment revealed that ubiquitination of H2B was enhanced at the E2F1-binding sites upon serum stimulation, which was diminished with knockdown of CDCA7L ( Figure 7E ). This finding is consistent with the previous notion that UbH2B correlates with gene activation and transcriptional elongation (Minsky et al., 2008) . Together, these data revealed that a series of covalent modifications initiated by Pc2-mediated SUMOylation of E2F1 leads to the subsequent H2B ubiquitination and the activation of a cohort of growth-control genes. (F) Effect of knockdown of Pc2, Bmi1, and PHC1 on relocation of MCM3 locus between PcG bodies and ICGs. HeLa cells microinjected with indicated siRNAs were serum-starved followed by restimulation, and immuno-FISH analyses were performed using antibodies and FISH probes as indicated. (G) Interaction between endogenous Pc2 and other core components of the PRC1 complex demonstrated by coimmunoprecipitation of Pc2K191me 2 with Bmi1, Ring1A, and PHC1 in HeLa cell extracts. The input represents 10% of the protein amount used for immunoprecipitation.
(H) KDM4C is required for serum-induced dissociation of the MCM3 locus from PcG bodies. HeLa cells microinjected with control siRNA or validated siRNA against KDM4C were serum-starved followed by restimulation, and immuno-FISH analyses were performed using Ring1A antibodies and probes targeting the MCM3 locus. (I) Demethylated Pc2 is required for relocation of the MCM3 locus. HeLa cells microinjected with blank vector, Pc2 WT, or K191R mutant were serum-starved followed by restimulation, and immuno-FISH analyses were performed using Ring1A, SC35 antibodies, and probes targeting the MCM3 locus. Statistical analyses on colocalization of MCM3 locus with Ring1A staining (left panel) and SC35 staining (right panel) were shown. For (A), (B), (C) , (D) , and (E), left panels show representative images, and right panels show statistical analyses. Mean ± SEM, *p < 0.05 and **p < 0.01. See also Figure S4 . 
DISCUSSION
Orchestrating precise spatial and temporal patterns of gene expression is crucial for the normal development of all organisms and maintenance of homeostasis. DNA-binding transcription factors, chromatin modifiers, and dynamic positioning of particular loci in nuclei are all essential to establish precise transcriptional regulation and achieve the correct patterns of gene expression. Here, we have elucidated how a nonhistone methylation event and the resultant specific ncRNA associations spatially modulate signal-induced nuclear architecture alteration, which underlies regulation of transcription units controlling cell-growth programs in both normal and transformed cells. Our studies have revealed that the methylation/demethylation of a single protein associated with E2F1-bound growth-control genes, Pc2, is responsible for the physical relocation of these transcription units from PcG bodies, in which their expression is repressed, to ICGs, in which their expression is activated (Figure 7F) . Unexpectedly, this reflects the differential interactions of methylated versus unmethylated Pc2 with two distinct ncRNAs that are located in distinct subnuclear architectural compartments ( Figure 7F ). In the case of Pc2, methylation controls the protein's interaction with two distinct ncRNAs, TUG1 and NEAT2, which results in the exclusive subnuclear localization of methylated and unmethylated Pc2 in PcG bodies and ICGs, respectively. Methylated Pc2 may represent an important antimitogenic signal and, under certain stimuli, a stress-induced modification mark required for growth-control gene repression and senescence, whereas unmethylated Pc2 is essential for physiological growth-control gene expression and cell proliferation.
TUG1, previously reported to interact with the PRC2 complex (Khalil et al., 2009) , is localized in PcG bodies to serve as a scaffold by interacting with Suv39h1-methylated Pc2, which relocates growth-control transcription units and brings them in proximity with specific corepressor machinery. In contrast, NEAT2 interacts with several proteins associated with gene activation. These ncRNAs promote the relocation of growth-control genes in response to mitogenic signals and are likely to facilitate the repression/activation of the encoded transcription units based both on their association with multiple coregulating complexes and on actions to modulate histone marks preferred by ''readers'' of the histone code. Indeed, the loss of TUG1 causes signal-independent activation of growth by failure to recruit growth-control gene loci to PcG bodies, whereas, conversely, the loss of NEAT2 inhibits growth, even in the presence of growth signals, with a failure to relocate the growth-control genes to ICGs.
This dynamic process is apparently dependent on a histone demethylase, KDM4C, that facilitates signal-dependent relocation of growth-control genes between distinct subnuclear architectural structures, with two ncRNAs serving as subnuclear molecular scaffolds. Our data have thus identified Pc2-ncRNA interactions as a key mechanism that determines the relative positioning of a growth-control gene regulatory program with respect to subnuclear architectural structures; however, we cannot absolutely exclude the possibility of a rapid assembly of subnuclear architectural structures in situ on the regulated promoters.
Consistent with our ncRNA pull-down results, the promoters interacting with TUG1 are postulated to present multiple epigenomic regulators that might also modulate histone marks, including the H3K9 methyltransferase RIZ1, the H3K27 methyltransferase EZH2, and the H3K4 demethylase JARID1A. In contrast, the promoters associated with NEAT2 in ICGs exhibit low levels of H3K9me 2/3 but high levels of H3K36me 3 and H3K4me 3 , perhaps regulated by interaction of NEAT2 with LSD1, SET2, and MLL. These data suggest the potential importance of these two ncRNAs as platforms for organizing a coordinated repression or activation program, respectively. Taken together, our findings highlight the large network of long ncRNAs, together with their associated protein complexes, as key components of the subnuclear architectural structures, each acting as a ''sensor'' for specific cohorts of regulated gene programs in response to signal-induced modifications that license gene-regulatory region-ncRNA interactions. Although Pc2 methylation appears to be the key determinant for relocation of growth-control genes, based on a methylation/ demethylation-dependent switch in preference for TUG1 or NEAT2 interactions, respectively, we are tempted to speculate that other ncRNAs recognize covalent modifications of other gene-associated proteins and exert their ncRNA scaffold functions in distinct subnuclear compartments to act as sensors for many regulated signaling pathways, and as modulators of ''reading'' marks on histone tails for a variety of chromodomaincontaining proteins and other histone code ''readers.'' Future exploration of interactions between subnuclear structure-specific ncRNAs and functionally distinctive protein cohorts is likely to uncover fresh insights into central strategies in development, homeostasis, and disease. subjected to immunoblotting with indicated antibodies. The Myc tag antibody was added to detect Myc-tagged peptides on position P21 as positive control. The binding specificity calculated by Array Analyses Software based on two arrays (images shown in Figures S5F-S5H) was shown. (G) TUG1 is localized in PcG bodies. HeLa cells microinjected with molecular beacon probes targeting TUG1 were subjected to immunostaining with Pc2K191me 2 antibodies.
(H) TUG1 and NEAT2 are required for serum-induced relocation of the MCM3 locus. HeLa cells microinjected with validated siRNA targeting TUG1 or NEAT2 were serum-starved followed by restimulation, and immuno-FISH analyses were performed using Ring1A, SC35 antibodies, and probes targeting the MCM3 locus. Statistical analyses on colocalization of MCM3 loci with Ring1A staining (left panel) and SC35 staining (right panel) are shown. (I and J) Effect of TUG1 or NEAT2 knockdown on serum-induced growth-control gene expression and cell proliferation. HeLa cells transfected with TUG1 or NEAT2 siRNA were serum-starved followed by restimulation, and relative mRNA levels of indicated genes and cell proliferation were determined by qRT-PCR (I) and flow cytometry (J).
(K) A list of TUG1 and NEAT2 ncRNA-associated proteins identified from two independent MS experiments. Mean ± SEM, *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S5 and Tables S1, S2 , and S3. His-tagged E2F1, recombinant E1, E2, and SUMO1 or SUMO1 mutant with or without RNase I treatment. The reaction products were subjected to immunoblotting using antibodies targeting E2F1 (left panel).
EXPERIMENTAL PROCEDURES
Cell Culture Human cervical cancer cell line HeLa, embryonic kidney cell line HEK293T, and human lung normal fibroblast IMR-90 were obtained from American Type Culture Collection (ATCC) and were cultured under standard conditions. Transfection of HeLa cells with siRNA and plasmid DNA was performed using Lipofectamine 2000 (Invitrogen). To induce growth-control gene expression and cell proliferation, HeLa cells transfected with plasmids or siRNAs as indicated were starved in serum-free media for 48 hr followed by stimulation with complete serum media for an additional 16 hr. IMR-90 fibroblasts were incubated in DMEM (GIBCO) medium supplemented with a suboptimal concentration of FBS (0.1%) for 4 days. Normal serum level (10%) was restored, and cells were harvested at 24 hr after release from low serum. A detailed description of methods is included in the Extended Experimental Procedures.
Antibody Generation
The rabbit anti-dimethyl-Pc2-specific antibody (Pc2K191me 2 ) was raised against a synthetic peptide CPDLGA (dimethyl-K) SHPPDKWAQ based on the human Pc2 sequence flanking lysine 191 (Abgent). The rabbit anti-unmethylated Pc2 antibody (Pc2K191) was obtained at the same time against peptide CPDLGAKSHPPDKWAQ (Abgent). The Pc2K191me 2 and Pc2K191
antibodies were used for immunoprecipitation, immunoblotting, ChIP, CLIP, and immunofluorescence.
Cell Proliferation Assay
Cell proliferation was measured by using the Click-iT EdU Cell Proliferation Assay Kit (Invitrogen) following the manufacturer's protocol. Data were recorded on a BD LSR II Flow Cytometer and analyzed by FlowJo flow cytometry analysis software (Tree Star, Inc.).
Immunofluorescence and Colocalization Analyses
Immunofluorescence of HeLa cells was carried out as previously described (Liu et al., 2010) . Images were acquired with a Zeiss Axioplan 2MOT Epifluorescent microscope (Carl Zeiss, Inc) and Hamamatsu ORCA ER black/white CCD camera in 633 oil immersion objective with each channel recorded once and all channels overlapped to generate overall images. For Ring1/ Bmi1 and Pc2K191me 2 immunofluorescence, rabbit anti-Ring1/Bmi1 and anti-Pc2K191me 2 IgGs were labeled by Zenon Alexa Fluor 594 and 488 Rabbit IgG Labeling Kits, respectively (Molecular Probe). Quantification of colocalization was determined by Pearson's correlation coefficient using commercially available Colocalizer Pro software, and the analysis was performed on at least 100 cells per condition with three independent experiments.
Immunofluorescence In Situ Hybridization
Cell nuclei isolation and immuno-FISH were carried out according to a method previously described (Lavrov et al., 2004) , and the probes were commercially labeled by Empire Genomics and are listed in Extended Experimental Procedures. At least 100 cells were counted in each experiment for statistical analysis.
In Vivo Crosslinking and Immunoprecipitation Assay CLIP analyses of methylated and unmethylated Pc2 were performed as previously described (Ule et al., 2005) . Briefly, cells were ultraviolet (UV) irradiated to covalently crosslink RNA-protein complexes. After UV irradiation, cells were lysed, and the RNA was partially digested, allowing a small fragment to remain attached to protein. RNA-protein complexes of interest were then partially purified by immunoprecipitation, and noncovalently associated RNAs were removed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). These purified RNA-protein complexes were isolated and treated with proteinase K, which removes protein but leaves intact RNAs. The recovered RNAs were subjected to RNA linker ligation, RT-PCR amplification, and sequencing.
Molecular Beacon and RNA FISH Custom-designed molecular beacon targeting TUG1 was synthesized by IDT. RNA FISH was performed using Stellaris RNA FISH technology according to manufacturer's instruction (Biosearch Technologies, Inc.). Stellari RNA FISH probes targeting TUG1 and NEAT2 were designed at http://www. singlemoleculefish.com/designer.html.
Data Analysis and Statistics
Relative quantities of gene expression level were normalized to Actin. The relative quantities of ChIP samples were normalized by individual inputs, respectively. Results are reported as mean ± standard error of the mean (SEM) of three independent experiments. Comparisons were performed using twotailed paired Student's t test. *p < 0.05, **p < 0.01, and ***p < 0.001. (A) CDCA7L interacts with K266-SUMOylated E2F1. FLAG-E2F1 immunoprecipitates from HeLa cells were separated by SDS-PAGE followed by silver staining. The band indicated was cut and subjected to MS analysis.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental
